pert_id,cmap_name,canonical_smiles,smiles_len
BRD-K43002773,GDC-0068,C[C@@H]1C[C@H](C2=C1C(=NC=N2)N3CCN(CC3)C(=O)[C@H](CNC(C)C)C4=CC=C(C=C4)Cl)O,75
BRD-A50998626,palomid-529,COc1ccc(COc2cc3oc(=O)c4cc(ccc4c3cc2OC)C(C)O)cc1,47
BRD-K70301465,ibrutinib,Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)[C@@H]1CCCN(C1)C(=O)C=C,61
BRD-K68407802,KIN001-055,COc1cc2ncnc(Nc3cc(Br)c(O)c(Br)c3)c2cc1OC,40
BRD-K42828737,sunitinib,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2/C(=O)Nc3ccc(F)cc23)c1C,54
BRD-A12230535,nutlin-3,COc1ccc(C2=NC(C(N2C(=O)N2CCNC(=O)C2)c2ccc(Cl)cc2)c2ccc(Cl)cc2)c(OC(C)C)c1,73
BRD-K00317371,RITA,OCc1ccc(s1)-c1ccc(o1)-c1ccc(CO)s1,33
BRD-K64538373,Ro-4987655,OCCONC(=O)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F,50
BRD-A67373739,AICA-ribonucleotide,NC(=O)c1ncn(C2OC(COP(O)(O)=O)C(O)C2O)c1N,40
BRD-K29313308,HDAC3-selective,CC(=O)Nc1ccc(cc1)C(=O)Nc1ccc(F)cc1N,35
BRD-K83837640,JNJ-26481585,Cn1cc(CNCC2CCN(CC2)c2ncc(cn2)C(=O)NO)c2ccccc12,46
BRD-K12184916,NVP-BEZ235,Cn1c2cnc3ccc(cc3c2n(-c2ccc(cc2)C(C)(C)C#N)c1=O)-c1cnc2ccccc2c1,62
BRD-K40175214,torin-1,CCC(=O)N1CCN(CC1)c1ccc(cc1C(F)(F)F)-n1c2c(ccc1=O)cnc1ccc(cc21)-c1cnc2ccccc2c1,77
BRD-K68174511,torin-2,Nc1ccc(cn1)-c1ccc2ncc3ccc(=O)n(-c4cccc(c4)C(F)(F)F)c3c2c1,57
BRD-K61128465,mdivi-1,COc1cc(c(Cl)cc1Cl)-n1c(=S)[nH]c2ccccc2c1=O,42
BRD-K97056771,GNF-2,NC(=O)c1cccc(c1)-c1cc(Nc2ccc(OC(F)(F)F)cc2)ncn1,47
BRD-K78659596,ixazomib,CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O,45
BRD-K63923597,barasertib-HQPA,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1,59
BRD-K24859147,KIN001-242,COCCNCCCn1c(C(=O)CF)c(-c2ccc(C)cc2)c2c(N)ncnc12,47
BRD-K75844781,mCPP,Clc1cccc(c1)N1CCNCC1,20
BRD-K72004355,CFTRinh-172,OC(=O)c1ccc(cc1)C=C1SC(=S)N(C1=O)c1cccc(c1)C(F)(F)F,51
BRD-K65285700,GP-1a,Cc1ccc-2c(Cc3c(nn(c-23)-c2ccc(Cl)cc2Cl)C(=O)NN2CCCCC2)c1,56
BRD-K34608650,GP-2a,Cc1ccc-2c(Cc3c(nn(c-23)-c2ccc(Cl)cc2Cl)C(=O)NC2CCCCC2)c1,56
BRD-K20755323,SKI-II,Oc1ccc(Nc2nc(cs2)-c2ccc(Cl)cc2)cc1,34
BRD-K01824921,DPCPX,CCCn1c2[nH]c(nc2c(=O)n(CCC)c1=O)C1CCCC1,39
BRD-K62965247,tipifarnib-P2,Cn1cncc1[C@@](N)(c1ccc(Cl)cc1)c1ccc2n(C)c(=O)cc(-c3cccc(Cl)c3)c2c1,66
BRD-K30572193,CTEP,Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(OC(F)(F)F)cc1,48
BRD-K60690191,MPEP,Cc1cccc(n1)C#Cc1ccccc1,22
BRD-K30421593,timolol,CC(C)(C)NC[C@@H](O)COc1nsnc1N1CCOCC1,36
BRD-K19796430,sonidegib,C[C@H]1CN(C[C@@H](C)O1)c1ccc(NC(=O)c2cccc(-c3ccc(OC(F)(F)F)cc3)c2C)cn1,70
BRD-K09186807,KIN001-244,Fc1ccc(Cn2cccc(C(=O)N[C@@H](COc3ccc4[nH]c(=O)[nH]c4c3)c3ccccc3)c2=O)cc1F,72
BRD-A03249105,ICI-182780,C[C@]12CC[C@H]3C([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31,87
BRD-A16035238,SAR-405838,CC(C)(C)CC1NC(C(c2cccc(Cl)c2F)C11C(=O)Nc2cc(Cl)ccc12)C(=O)NC1CCC(O)CC1,70
BRD-K60237333,niacin,OC(=O)c1cccnc1,14
BRD-A76747559,rutin,C[C@@H]1O[C@@H](OC[C@H]2OC(Oc3c(oc4cc(O)cc(O)c4c3=O)-c3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O,117
BRD-K84925803,T-5224,OC(=O)CCc1cc(ccc1OCc1ccc2c(O)noc2c1)C(=O)c1ccc(OC2CCCC2)cc1O,60
BRD-K36927236,glibenclamide,COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3,56
BRD-K11267252,alectinib,CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N1CCC(CC1)N1CCOCC1,65
BRD-K72827473,CEP-37440,CNC(=O)c1ccccc1Nc1nc(Nc2ccc3C[C@H](CCCc3c2OC)N2CCN(CCO)CC2)ncc1Cl,65
BRD-K22149900,ceritinib,CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1,65
BRD-K78431006,crizotinib,C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl,56
BRD-K50140147,NVP-TAE684,COc1cc(ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1)N1CCC(CC1)N1CCN(C)CC1,71
BRD-K71480163,GDC-0068,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c1ncnc2[C@@H](O)C[C@@H](C)c12)c1ccc(Cl)cc1,71
BRD-A87137733,GSK-690693,CCn1c(nc2c(ncc(OCC3CCCNC3)c12)C#CC(C)(C)O)-c1nonc1N,51
BRD-K68065987,MK-2206,NC1(CCC1)c1ccc(cc1)-c1nc2ccn3c(n[nH]c3=O)c2cc1-c1ccccc1,55
BRD-K56301217,ABT-737,CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(cc1[N+]([O-])=O)S(=O)(=O)NC(=O)c1ccc(cc1)N1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1,104
BRD-K19295594,gossypol,CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)-c1c(C)cc2c(C(C)C)c(O)c(O)c(C=O)c2c1O,75
BRD-K82746043,navitoclax,CC1(C)CCC(=C(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCOCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)C1)c1ccc(Cl)cc1,122
BRD-K15600710,obatoclax,COC1=CC(=NC1=C/c1[nH]c(C)cc1C)c1cc2ccccc2[nH]1,46
BRD-K28360340,TW-37,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(cc2)S(=O)(=O)c2ccccc2C(C)(C)C)c(O)c(O)c1O,72
BRD-K87782578,AVL-292,COCCOc1ccc(Nc2ncc(F)c(Nc3cccc(NC(=O)C=C)c3)n2)cc1,49
BRD-K48443249,CNX-774,CNC(=O)c1cc(Oc2ccc(Nc3ncc(F)c(Nc4cccc(NC(=O)C=C)c4)n3)cc2)ccn1,62
BRD-A30984645,GDC-0834,CN1CCN(C)C(=O)C1c1ccc(Nc2nc(cn(C)c2=O)-c2cccc(NC(=O)c3cc4CCCCc4s3)c2C)cc1,73
BRD-A35869383,ibrutinib,Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)C1CCCN(C1)C(=O)C=C,56
BRD-A30655177,LFM-A13,CC(=O)C(C#N)C(=O)Nc1cc(Br)ccc1Br,32
BRD-K87909389,alvocidib,CN1CC[C@@H]([C@H](O)C1)c1c(O)cc(O)c2c1oc(cc2=O)-c1ccccc1Cl,58
BRD-K13390322,AT-7519,Clc1cccc(Cl)c1C(=O)Nc1c[nH]nc1C(=O)NC1CCNCC1,44
BRD-K43389698,BMS-387032,CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1,42
BRD-K79090631,CGP-60474,OCCCNc1cc(ccn1)c2ccnc(Nc3cccc(Cl)c3)n2,38
BRD-K13662825,dinaciclib,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N1CCCC[C@H]1CCO,53
BRD-K11636097,JNJ-7706621,Nc1nc(Nc2ccc(cc2)S(N)(=O)=O)nn1C(=O)c1c(F)cccc1F,48
BRD-K51313569,palbociclib,CC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCNCC3)nc2n(C2CCCC2)c1=O,55
BRD-K64800655,PHA-793887,CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C,49
BRD-K60997853,PHA-848125,CNC(=O)c1nn(C)c-2c1C(C)(C)Cc1cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc-21,61
BRD-K07691486,roscovitine,CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1,44
BRD-K46056750,AZD-7762,NC(=O)Nc1cc(sc1C(=O)N[C@@H]1CCCNC1)-c1cccc(F)c1,47
BRD-K86525559,AZD-7762,NC(=O)Nc1cc(sc1C(=O)N[C@H]1CCCNC1)-c1cccc(F)c1,46
BRD-K03063480,PF-477736,Cn1cc(cn1)-c1[nH]c2cc(NC(=O)[C@H](N)C3CCCCC3)cc3c2c1cn[nH]c3=O,62
BRD-A06352508,SB-218078,O=C1NC(=O)c2c1c1c3ccccc3n3C4CCC(O4)n4c5ccccc5c2c4c13,52
BRD-K75009076,SCH-900776,Cn1cc(cn1)-c1cnn2c(N)c(Br)c(nc12)[C@@H]1CCCNC1,46
BRD-K30466858,ellagic-acid,Oc1cc2c3c(oc(=O)c4cc(O)c(O)c(oc2=O)c34)c1O,42
BRD-K70463136,BAY-87-2243,Cc1cc(nn1Cc1ccnc(c1)N1CCN(CC1)C1CC1)-c1nc(no1)-c1ccc(OC(F)(F)F)cc1,66
BRD-K88551539,CAY-10585,COC(=O)c1ccc(O)c(NC(=O)COc2ccc(cc2)C2C3CC4CC(C3)CC2C4)c1,56
BRD-K51967704,BIIB-021,COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc23)c1C,37
BRD-K38852836,ganetespib,CC(C)c1cc(-c2n[nH]c(=O)n2-c2ccc3n(C)ccc3c2)c(O)cc1O,51
BRD-K11528507,geldanamycin,CO[C@H]1C[C@H](C)CC2=C(OC)C(=O)C=C(NC(=O)C(C)=CC=C/[C@H](OC)[C@@H](OC(N)=O)C(C)=C[C@H](C)[C@H]1O)C2=O,101
BRD-A19500257,geldanamycin,COC1CC(C)CC2=C(OC)C(=O)C=C(NC(=O)C(C)=CC=CC(OC)C(OC(N)=O)C(C)=CC(C)C1O)C2=O,75
BRD-K41859756,NVP-AUY922,CCNC(=O)c1noc(c1-c1ccc(CN2CCOCC2)cc1)-c1cc(C(C)C)c(O)cc1O,57
BRD-K81473043,tanespimycin,CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)C(C)=CC=C/[C@H](OC)[C@@H](OC(N)=O)C(C)=C[C@H](C)[C@H]1O)C2=O,104
BRD-A61304759,tanespimycin,COC1CC(C)CC2=C(NCC=C)C(=O)C=C(NC(=O)C(C)=CC=CC(OC)C(OC(N)=O)C(C)=CC(C)C1O)C2=O,78
BRD-K13566078,BMS-345541,Cc1cnc2c(NCCN)nc3ccc(C)cc3n12,29
BRD-K47983010,BX-795,Ic1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCCNC(=O)c1cccs1,52
BRD-K14618467,IKK-16,O=C(N1CCC(CC1)N1CCCC1)c1ccc(Nc2nccc(n2)-c2cc3ccccc3s2)cc1,57
BRD-K51575138,TPCA-1,NC(=O)Nc1sc(cc1C(N)=O)-c1ccc(F)cc1,34
BRD-K88378636,withaferin-a,C[C@@H]([C@H]1CC[C@H]2[C@@H]3C[C@H]4O[C@]45[C@@H](O)C=CC(=O)[C@]5(C)[C@H]3CC[C@]12C)[C@H]6CC(=C(CO)C(=O)O6)C,108
BRD-K24576554,AT-9283,O=C(NC1CC1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1,50
BRD-K65928735,AZD-1480,C[C@H](Nc1ncc(Cl)c(Nc2cc(C)[nH]n2)n1)c1ncc(F)cn1,48
BRD-K53581288,baricitinib,CCS(=O)(=O)N1CC(CC#N)(C1)n1cc(cn1)-c1ncnc2[nH]ccc12,51
BRD-A27376179,lestaurtinib,C[C@]12OC(C[C@]1(O)CO)n1c3ccccc3c3c4C(=O)NCc4c4c5ccccc5n2c4c13,62
BRD-K12502280,TG-101348,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C,61
BRD-K36280065,tofacitinib,C[C@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CC#N,49
BRD-K59369769,tozasertib,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(Sc2ccc(NC(=O)C3CC3)cc2)n1,59
BRD-A60245366,AS-601245,N#CC(c1nc2ccccc2s1)c1ccnc(NCCc2cccnc2)n1,40
BRD-K01567962,pyrazolanthrone,O=C1c2ccccc2-c2n[nH]c3cccc1c23,30
BRD-K66538826,amuvatinib,S=C(NCc1ccc2OCOc2c1)N1CCN(CC1)c1ncnc2c3ccccc3oc12,49
BRD-K86930074,cediranib,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,50
BRD-K49328571,dasatinib,Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1,55
BRD-K92723993,imatinib,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,61
BRD-K71035033,masitinib,CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nc(cs3)-c3cccnc3)c2)CC1,60
BRD-K13646352,midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)n1c3ccccc3c3c4CNC(=O)c4c4c5ccccc5n2c4c13)N(C)C(=O)c1ccccc1,90
BRD-K99616396,motesanib,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc12,43
BRD-K74514084,pazopanib,CN(c1ccc2c(C)n(C)nc2c1)c1ccnc(Nc2ccc(C)c(c2)S(N)(=O)=O)n1,57
BRD-K16730910,regorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1,60
BRD-K23984367,sorafenib,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1,57
BRD-K89162000,tandutinib,COc1cc2c(ncnc2cc1OCCCN1CCCCC1)N1CCN(CC1)C(=O)Nc1ccc(OC(C)C)cc1,62
BRD-K84564571,telatinib,CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1,47
BRD-K64925568,AMG-232,CC(C)[C@@H](CS(=O)(=O)C(C)C)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1,90
BRD-K17349619,HLI-373,CN(C)CCCNc1c2ccccc2n(C)c2nc(=O)n(C)c(=O)c12,43
BRD-K65924316,serdemetan,C(Cc1c[nH]c2ccccc12)Nc1ccc(Nc2ccncc2)cc1,40
BRD-K60219430,serdemetan,C(Cc1c[nH]c2ccccc12)Nc1cccc(Nc2ccncc2)c1,40
BRD-A16035238,SAR405838,CC(C)(C)CC1NC(C(c2cccc(Cl)c2F)C11C(=O)Nc2cc(Cl)ccc12)C(=O)NC1CCC(O)CC1,70
BRD-K73368362,BIX-02189,CN(C)Cc1cccc(NC(c2ccccc2)=C2/C(=O)Nc3cc(ccc23)C(=O)N(C)C)c1,59
BRD-K49865102,PD-0325901,OC[C@@H](O)CONC(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F,46
BRD-K05104363,PD-184352,Fc1ccc(C(=O)NOCC2CC2)c(Nc2ccc(I)cc2Cl)c1F,41
BRD-K62810658,PD-98059,COc1cccc(-c2cc(=O)c3ccccc3o2)c1N,32
BRD-K85751432,refametinib,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1,59
BRD-K57080016,selumetinib,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(cc12)C(=O)NOCCO,46
BRD-K12343256,trametinib,CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O,70
BRD-K18787491,U-0126,NC(Sc1ccccc1N)=C(C#N)/C(C#N)=C(N)Sc1ccccc1N,43
BRD-K79404599,enzastaurin,Cn1cc(C2=C(C(=O)NC2=O)c2cn(C3CCN(Cc4ccccn4)CC3)c3ccccc23)c2ccccc12,66
BRD-K16761703,sotrastaurin,CN1CCN(CC1)c1nc(C2=C(C(=O)NC2=O)c2c[nH]c3ccccc23)c2ccccc2n1,59
BRD-K64890080,BI-2536,CC[C@H]1N(C2CCCC2)c2nc(Nc3ccc(cc3OC)C(=O)NC3CCN(C)CC3)ncc2N(C)C1=O,66
BRD-K92428232,GSK-461364,C[C@@H](Oc1cc(sc1C(N)=O)-n1cnc2ccc(CN3CCN(C)CC3)cc12)c1ccccc1C(F)(F)F,69
BRD-K90382497,GW-843682X,COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(s3)C(N)=O)c2cc1OC,55
BRD-K70511574,HMN-214,COc1ccc(cc1)S(=O)(=O)N(C(C)=O)c1ccccc1C=Cc1cc[n+]([O-])cc1,58
BRD-K27305650,LY-294002,O=c1cc(oc2c(cccc12)-c1ccccc1)N1CCOCC1,37
BRD-K83699324,NMS-1286937,CN1CCN(CC1)c1ccc(OC(F)(F)F)c(Nc2ncc3CCc4c(nn(CCO)c4-c3n2)C(N)=O)c1,66
BRD-K69776681,volasertib,CC[C@H]1N(C(C)C)c2nc(Nc3ccc(cc3OC)C(=O)N[C@H]3CC[C@@H](CC3)N3CCN(CC4CC4)CC3)ncc2N(C)C1=O,88
BRD-K05804044,AZ-628,Cc1ccc(NC(=O)c2cccc(c2)C(C)(C)C#N)cc1Nc1ccc2ncn(C)c(=O)c2c1,59
BRD-K09951645,dabrafenib,CC(C)(C)c1nc(c(s1)-c1ccnc(N)n1)-c1cccc(NS(=O)(=O)c2c(F)cccc2F)c1F,65
BRD-K67578145,GDC-0879,OCCn1cc(c(n1)-c1ccncc1)-c1ccc2c(CCC2=N/O)c1,43
BRD-K07859598,GW-5074,Oc1c(Br)cc(cc1Br)C=C1/C(=O)Nc2ccc(I)cc12,40
BRD-K16478699,PLX-4720,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F,52
BRD-K56343971,vemurafenib,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)-c2ccc(Cl)cc2)c1F,63
BRD-K99964838,bosutinib,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl,59
BRD-K19540840,saracatinib,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c5OCOc5ccc4Cl)ncnc3c2)CC1,57
BRD-K12735121,TG-100801,Cc1cc(cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12)-c1cc(OC(=O)c2ccccc2)ccc1Cl,67
BRD-K20285085,fostamatinib,COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)Nc4n3)n2)cc(OC)c1OC,57
BRD-K76719364,GS-9973,C1CN(CCO1)c1ccc(Nc2nc(cn3ccnc23)-c2ccc3cn[nH]c3c2)cc1,53
BRD-K66175015,afatinib,CN(C)CC=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1,59
BRD-K46386702,ARRY-334543,C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1,57
BRD-K70914287,BIBX-1382,CN1CCC(CC1)Nc1ncc2ncnc(Nc3ccc(F)c(Cl)c3)c2n1,44
BRD-K50168500,canertinib,Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)C=C)cc23)cc1Cl,53
BRD-K76908866,CP-724714,COCC(=O)NCC=Cc1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1,55
BRD-K57169635,dacomitinib,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=CCN1CCCCC1,52
BRD-K85402309,dovitinib,CN1CCN(CC1)c1ccc2nc([nH]c2c1)-c1c(N)c2c(F)cccc2[nH]c1=O,55
BRD-K70401845,erlotinib,COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC,40
BRD-K64052750,gefitinib,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,46
BRD-K19687926,lapatinib,CS(=O)(=O)CCNCc1ccc(o1)-c1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1,68
BRD-K85606544,neratinib,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)C=CCN(C)C,64
BRD-K08799216,pelitinib,CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)C=CCN(C)C,55
BRD-K33610132,rociletinib,COc1cc(ccc1Nc1ncc(c(Nc2cccc(NC(=O)C=C)c2)n1)C(F)(F)F)N1CCN(CC1)C(C)=O,69
BRD-K80343549,TAK-285,CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(c4)C(F)(F)F)c(Cl)c3)c12,66
BRD-K77625799,vandetanib,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1,45
BRD-K72420232,WZ-4002,COc1cc(ccc1Nc1ncc(Cl)c(Oc2cccc(NC(=O)C=C)c2)n1)N1CCN(C)CC1,58
BRD-K28428262,brivanib,C[C@@H](O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,49
BRD-A21584801,brivanib,CC(O)COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C,44
BRD-K56405753,MK-2461,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(cc3c(=O)c2c1)-c1cnn(C)c1,66
BRD-K49075727,nintedanib,COC(=O)c1ccc2c(NC(=O)C2=C(/Nc2ccc(cc2)N(C)C(=O)CN2CCN(C)CC2)c2ccccc2)c1,71
BRD-K55966568,orantinib,Cc1[nH]c(C=C2/C(=O)Nc3ccccc23)c(C)c1CCC(O)=O,44
BRD-K97764662,PD-173074,CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1,62
BRD-K40738845,BMS-777607,CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1,62
BRD-K68488863,ENMD-2076,CN1CCN(CC1)c1cc(Nc2cc(C)[nH]n2)nc(C=Cc2ccccc2)n1,48
BRD-K21718444,KW-2449,O=C(N1CCNCC1)c1ccc(cc1)C=Cc1n[nH]c2ccccc12,42
BRD-K44227013,ponatinib,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1,65
BRD-K93918653,quizartinib,CC(C)(C)c1cc(NC(=O)Nc2ccc(cc2)-c2cn3c(n2)sc2cc(OCCN4CCOCC4)ccc32)no1,68
BRD-K82928847,ACY-1215,ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c1ccccc1)c1ccccc1,48
BRD-K17743125,belinostat,ONC(=O)C=Cc1cccc(c1)S(=O)(=O)Nc1ccccc1,38
BRD-K56957086,dacinostat,OCCN(CCc1c[nH]c2ccccc12)Cc1ccc(C=CC(=O)NO)cc1,45
BRD-K77908580,entinostat,Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1,42
BRD-K02130563,panobinostat,Cc1[nH]c2ccccc2c1CCNCc1ccc(C=CC(=O)NO)cc1,41
BRD-K12867552,PCI-24781,CN(C)Cc1c(oc2ccccc12)C(=O)NCCOc1ccc(cc1)C(=O)NO,47
BRD-K88742110,PCI-34051,COc1ccc(Cn2ccc3ccc(cc23)C(=O)NO)cc1,35
BRD-K28822270,resminostat,CN(C)Cc1ccc(cc1)S(=O)(=O)n1ccc(c1)C=CC(=O)NO,44
BRD-K61397605,romidepsin,CC=C1/NC(=O)[C@H]2CSSCCC=C[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,83
BRD-K86797399,SB-939,CCCCc1nc2cc(ccc2n1CCN(CC)CC)C=CC(=O)NO,38
BRD-K00627859,tubastatin-a,CN1CCc2c(C1)c1ccccc1n2Cc1ccc(cc1)C(=O)NO,40
BRD-K41260949,valproic-acid,CCCC(CCC)C(O)=O,15
BRD-K81418486,vorinostat,ONC(=O)CCCCCCC(=O)Nc1ccccc1,27
BRD-K69932463,AZD-8055,COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C,61
BRD-K13514097,everolimus,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OCCO,188
BRD-K13154216,everolimus,CO[C@@H]1C[C@H](C[C@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OCCO,186
BRD-K67566344,KU-0063794,COc1ccc(cc1CO)-c1ccc2c(nc(nc2n1)N1C[C@H](C)O[C@H](C)C1)N1CCOCC1,63
BRD-K07310275,PF-04691502,COc1ccc(cn1)-c1cc2c(C)nc(N)nc2n([C@H]2CC[C@@H](CC2)OCCO)c1=O,60
BRD-K67868012,PI-103,Oc1cccc(c1)-c1nc(N2CCOCC2)c2oc3ncccc3c2n1,41
BRD-A79768653,sirolimus,COC1CC(CC(C)C2CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C(C)C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N3CCCCC3C(=O)O2)OC)CCC1O,118
BRD-A62025033,temsirolimus,COC1CC(CC(C)C2CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C(C)C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N3CCCCC3C(=O)O2)OC)CCC1OC(=O)C(C)(CO)CO,133
BRD-K56291712,voxtalisib,CCn1c2nc(N)nc(C)c2cc(-c2cc[nH]n2)c1=O,37
BRD-A45498368,WYE-125132,CNC(=O)Nc1ccc(cc1)-c1nc(N2CC3CCC(C2)O3)c2cnn(C3CCC4(CC3)OCCO4)c2n1,66
BRD-K00615600,AG-14361,CN(C)Cc1ccc(cc1)-c1nc2cccc3C(=O)NCCn1c23,40
BRD-K61314889,endo-IWR-1,O=C(Nc1cccc2cccnc12)c1ccc(cc1)N1C(=O)[C@H]2[C@@H]3C[C@@H](C=C3)[C@H]2C1=O,73
BRD-K11153516,iniparib,NC(=O)c1ccc(I)c(c1)[N+]([O-])=O,31
BRD-K02113016,olaparib,Fc1ccc(Cc2n[nH]c(=O)c3ccccc23)cc1C(=O)N1CCN(CC1)C(=O)C1CC1,58
BRD-K88560311,rucaparib,CNCc1ccc(cc1)-c1[nH]c2cc(F)cc3C(=O)NCCc1c23,43
BRD-K95142244,talazoparib,Cn1ncnc1[C@@H]1[C@H](Nc2cc(F)cc3c2c1n[nH]c3=O)c1ccc(F)cc1,57
BRD-K12737986,veliparib,C[C@]1(CCCN1)c1nc2c(cccc2[nH]1)C(N)=O,37
BRD-K87142802,veliparib,C[C@@]1(CCCN1)c1nc2c(cccc2[nH]1)C(N)=O,38
BRD-K54997624,alpelisib,Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(c1)C(C)(C)C(F)(F)F,59
BRD-K41895714,AS-605240,O=C1NC(=O)C(S1)=C/c1ccc2nccnc2c1,32
BRD-K58772419,AZD-6482,C[C@@H](Nc1ccccc1C(O)=O)c1cc(C)cn2c1nc(cc2=O)N1CCOCC1,53
BRD-K42191735,buparlisib,Nc1cc(c(cn1)-c1cc(nc(n1)N1CCOCC1)N1CCOCC1)C(F)(F)F,50
BRD-K52911425,GDC-0941,CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3[nH]ncc23)CC1,63
BRD-K60866521,idelalisib,CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1,56
BRD-K44844162,taselisib,CC(C)n1nc(C)nc1-c1cn2CCOc3cc(ccc3-c2n1)-c1cnn(c1)C(C)(C)C(N)=O,62
BRD-A41692738,TGX-221,CC(Nc1ccccc1)c1cc(C)cn2c1nc(cc2=O)N1CCOCC1,42
BRD-A75409952,wortmannin,COCC1OC(=O)c2coc3c2C1(C)C1=C(C2CCC(=O)C2(C)CC1OC(C)=O)C3=O,58
BRD-K95901403,XL-147,Cc1ccc(cc1)S(=O)(=O)Nc1nc2ccccc2nc1Nc1ccc2nsnc2c1,49
BRD-K63068307,ZSTK-474,FC(F)c1nc2ccccc2n1-c1nc(nc(n1)N1CCOCC1)N1CCOCC1,47
BRD-K72215350,acexamic-acid,CC(=O)NCCCCCC(O)=O,18
BRD-A59001851,ginkgolide-b,C[C@@H]1C(=O)O[C@H]2[C@H](O)C34[C@H]5C[C@@H](C(C)(C)C)[C@@]33[C@@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,105
BRD-A82395837,ginkgolide-b,C[C@H]1C(=O)O[C@H]2[C@@H](O)C34[C@@H]5C[C@@H](C(C)(C)C)C33[C@H](O)C(=O)O[C@H]3O[C@]4(C(=O)O5)[C@@]12O,101
BRD-K33336844,cryptotanshinone,C[C@H]1COC2=C1C(=O)C(=O)c1c2ccc2c1CCCC2(C)C,43
BRD-K14529030,meisoindigo,CN1C(=O)C(c2ccccc12)=C1C(=O)Nc2ccccc12,38
BRD-K35960502,niclosamide,Oc1ccc(Cl)cc1C(=O)Nc1ccc(cc1Cl)[N+]([O-])=O,43
BRD-A61767428,ursolic-acid,C[C@@H]1C[C@H](C2CC[C@]3(C)C(=CC[C@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]2[C@@H]1C)C(O)=O,103
BRD-A45889380,mepacrine,CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,43
BRD-K71221037,birinapant,CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c([nH]c2cc(F)ccc12)-c1[nH]c2cc(F)ccc2c1C[C@@H]1C[C@H](O)CN1C(=O)[C@H](CC)NC(=O)[C@H](C)NC,141
BRD-K55512740,MK-8033,Cn1cc(cn1)-c1cnc2ccc3ccc(CS(=O)(=O)NCc4ccccn4)cc3c(=O)c2c1,58
BRD-K73319509,PF-04217903,OCCn1cc(cn1)-c1cnc2nnn(Cc3ccc4ncccc4c3)c2n1,43
BRD-K95435023,PHA-665752,Cc1[nH]c(C=C2/C(=O)Nc3ccc(cc23)S(=O)(=O)Cc2c(Cl)cccc2Cl)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1,87
BRD-K59184148,SB-216763,Cn1cc(C2=C(C(=O)NC2=O)c2ccc(Cl)cc2Cl)c2ccccc12,46
BRD-K94176593,TWS-119,Nc1cccc(c1)-c1cc2c(Oc3cccc(O)c3)ncnc2[nH]1,42
BRD-K34581968,BMS-536924,Cc1cc(cc2[nH]c(nc12)-c1c(NC[C@@H](O)c2cccc(Cl)c2)cc[nH]c1=O)N1CCOCC1,68
BRD-K04833372,GSK-1904529A,CCc1cc(Nc2nccc(n2)-c2c(nc3ccccn23)-c2ccc(OC)c(c2)C(=O)Nc2c(F)cccc2F)c(OC)cc1N1CCC(CC1)N1CCN(CC1)S(C)(=O)=O,106
BRD-K86118762,linsitinib,C[C@@]1(O)C[C@@H](C1)c1nc(-c2ccc3ccc(nc3c2)-c2ccccc2)c2c(N)nccn12,65
BRD-K07667918,linsitinib,C[C@@]1(O)CC(C1)c1nc(-c2ccc3ccc(nc3c2)-c2ccccc2)c2c(N)nccn12,60
BRD-K29905972,axitinib,CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1,45
BRD-K99749624,linifanib,Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)-c2cccc3[nH]nc(N)c23)c1,51
BRD-K95763993,trapidil,CCN(CC)c1cc(C)nc2ncnn12,23
BRD-K51544265,cabozantinib,COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3)c2cc1OC,61
BRD-K03449891,foretinib,COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCOCC1,72
BRD-K69001009,golvatinib,CN1CCN(CC1)C1CCN(CC1)C(=O)Nc1cc(Oc2ccc(NC(=O)C3(CC3)C(=O)Nc3ccc(F)cc3)c(F)c2)ccn1,81
BRD-K63504947,semaxanib,Cc1cc(C)c(C=C2/C(=O)Nc3ccccc23)[nH]1,36
BRD-K53414658,tivozanib,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,52
BRD-K69023402,thapsigargin,CCCCCCCC(=O)O[C@@H]1[C@@H](OC(=O)/C(=CC)/C)C(=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(O)[C@H](C[C@](C)(OC(=O)C)[C@@H]12)OC(=O)CCC)C,124
BRD-K63343048,orlistat,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,68
BRD-K14653796,tasquinimod,COc1cccc2n(C)c(=O)c(C(=O)N(C)c3ccc(cc3)C(F)(F)F)c(O)c12,55
BRD-A17883755,lenalidomide,Nc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O,34
BRD-K03504028,amygdalin,OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O[C@@H](C#N)c3ccccc3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O,104
BRD-K38744518,betulinic-acid,CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@H]12)C(O)=O,105
BRD-K92991072,PAC-1,Oc1c(CC=C)cccc1C=NNC(=O)CN1CCN(Cc2ccccc2)CC1,44
BRD-K87718015,dynasore,Oc1ccc(C=NNC(=O)c2cc3ccccc3cc2O)cc1O,36
BRD-K88025533,fingolimod,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1,30
BRD-A84575140,pimobendan,COc1ccc(cc1)-c1nc2cc(ccc2[nH]1)C1=NNC(=O)CC1C,45
BRD-K14880289,GW-501516,Cc1nc(sc1CSc1ccc(OCC(O)=O)c(C)c1)-c1ccc(cc1)C(F)(F)F,52
BRD-A48430263,pioglitazone,CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1,39
BRD-A97437073,rosiglitazone,CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1,39
BRD-A13084692,troglitazone,Cc1c(C)c2OC(C)(COc3ccc(CC4SC(=O)NC4=O)cc3)CCc2c(C)c1O,53
BRD-K00521308,ATN-161,CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(N)=O,101
BRD-K57252450,cilengitide,CC(C)[C@@H]1N(C)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O,93
BRD-K74065929,doramapimod,Cc1ccc(cc1)-n1nc(cc1NC(=O)Nc1ccc(OCCN2CCOCC2)c2ccccc12)C(C)(C)C,63
BRD-K56195681,losmapimod,Cc1c(F)cc(cc1-c1ccc(cn1)C(=O)NCC(C)(C)C)C(=O)NC1CC1,51
BRD-K95880107,PH-797804,CNC(=O)c1ccc(C)c(c1)-n1c(C)cc(OCc2ccc(F)cc2F)c(Br)c1=O,54
BRD-A37704979,SB-203580,CS(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccncc1)-c1ccc(F)cc1,52
BRD-K52751261,TAK-715,CCc1nc(c(s1)-c1ccnc(NC(=O)c2ccccc2)c1)-c1cccc(C)c1,50
BRD-K24681473,YM-155,COCC[n+]1c(C)n(Cc2cnccn2)c2c1C(=O)c1ccccc1C2=O,46
BRD-K76703230,YM-155,COCCn1c2c(C(=O)c3ccccc3C2=O)[n+](Cc2cnccn2)c1C,46
BRD-A10012892,argatroban,C[C@@H]1CCN([C@@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)c1cccc2CC(C)CNc12,78
BRD-K38168441,dabigatran,Cn1c(CNc2ccc(cc2)C(N)=N)nc2cc(ccc12)C(=O)N(CCC(O)=O)c1ccccn1,60
BRD-K57041787,dabigatran-etexilate,CCCCCCOC(=O)N=C(N)c1ccc(NCc2nc3cc(ccc3n2C)C(=O)N(CCC(=O)OCC)c2ccccn2)cc1,72
BRD-K73504359,bivalirudin,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(O)=O,348
BRD-K14619660,altrenogest,C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(O)CC=C,55
BRD-K81672972,dinoprost,CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=C/CCCC(O)=O,60
BRD-K14870255,R-428,Nc1nc(Nc2ccc3CC[C@@H](CCc3c2)N2CCCC2)nn1-c1cc2CCCc3ccccc3-c2nn1,63
BRD-K68870568,flumatinib,CN1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc2cnc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1,69
BRD-K81528515,nilotinib,Cc1cn(cn1)-c1cc(NC(=O)c2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)cc(c1)C(F)(F)F,70
BRD-K90789829,nefazodone,CCc1nn(CCCN2CCN(CC2)c2cccc(Cl)c2)c(=O)n1CCOc1ccccc1,51
BRD-K58501140,TAK-875,Cc1cc(OCCCS(C)(=O)=O)cc(C)c1-c1cccc(COc2ccc3[C@H](CC(O)=O)COc3c2)c1,67
BRD-K64857848,XMD-885,COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCN(C)CC1,55
BRD-K68756823,FR-180204,Nc1[nH]nc2nnc(cc12)-c1c(nn2ccccc12)-c1ccccc1,44
BRD-K50387473,XMD-892,CCOc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)N1CCC(O)CC1,56
BRD-K43187018,GDC-0349,CCNC(=O)Nc1ccc(cc1)-c1nc2CN(CCc2c(n1)N1CCOC[C@@H]1C)C1COC1,58
BRD-K80700417,SGI-1776,CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1,48
BRD-K50691590,bortezomib,CC(C)C[C@@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)C1=CNC=CN1)B(O)O,58
BRD-K88510285,bortezomib,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O,54
BRD-K60230970,MG-132,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O,70
BRD-K04623885,BIBR-1532,CC(=C/C(=O)Nc1ccccc1C(O)=O)c1ccc2ccccc2c1,41
BRD-A69815203,cyclosporin-a,CCC1NC(=O)C(C(O)C(C)CC=CC)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,167
BRD-K97729603,pimecrolimus,CC[C@@H]1C=C(C)C[C@H](C)C[C@H](OC)[C@@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)C(C)=C[C@@H]1CC[C@@H](Cl)[C@@H](C1)OC,164
BRD-K55781385,BMS-927711,N[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)n2c3cccnc3[nH]c2=O)c2ncccc12)c1cccc(F)c1F,80
BRD-K66911501,MK-3207,Fc1cc(F)cc(c1)[C@@H]1CNC2(CCCC2)C(=O)N1CC(=O)Nc1ccc2C[C@]3(Cc2c1)C(=O)Nc1ncccc31,80
BRD-K91159026,telcagepant,Fc1cccc([C@@H]2CC[C@@H](NC(=O)N3CCC(CC3)n3c4cccnc4[nH]c3=O)C(=O)N(CC(F)(F)F)C2)c1F,82
BRD-K14993104,bemegride,CCC1(C)CC(=O)NC(=O)C1,21
BRD-K00662280,CL-218872,Cc1nnc2ccc(nn12)-c1cccc(c1)C(F)(F)F,35
BRD-K29220403,eszopiclone,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1,53
BRD-A66920069,fenigam,NCC(CC(O)=O)c1ccccc1,20
BRD-K90948141,indiplon,CN(C(C)=O)c1cccc(c1)-c1ccnc2c(cnn12)C(=O)c1cccs1,48
BRD-K82255054,propofol,CC(C)c1cccc(C(C)C)c1O,21
BRD-K46018455,bezafibrate,CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(O)=O,44
BRD-A93000692,ciglitazone,CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1,37
BRD-K96615647,AV-608,FC(F)(F)c1cc(cc(c1)C(F)(F)F)C(=O)N1CC[C@@H](C[C@H]1Cc1ccc(Cl)cc1)NC(=O)c1ccnc2ccccc12,85
BRD-K83508485,FK-888,CN(Cc1ccccc1)C(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)c1cn(C)c2ccccc12,87
BRD-K97428065,netupitant,CN(C(=O)C(C)(C)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)c1cnc(cc1-c1ccccc1C)N1CCN(C)CC1,75
BRD-K47095176,talnetant,CC[C@H](NC(=O)c1c(O)c(nc2ccccc12)-c1ccccc1)c1ccccc1,51
BRD-A12994259,pomalidomide,Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12,38
BRD-K46580984,phenserine,CN1CC[C@]2(C)[C@H]1N(C)c1ccc(OC(=O)Nc3ccccc3)cc21,49
BRD-K82234479,tramiprosate,NCCCS(O)(=O)=O,14
BRD-A93424738,dexamethasone-acetate,C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(C)=O,84
BRD-A15297126,fluocinolone-acetonide,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1CC1C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C,96
BRD-K63550407,erythromycin,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,174
BRD-K51677086,erythromycin-ethylsuccinate,CCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C,190
BRD-A77216878,manumycin-a,CCCC[C@@H](C)C=C(C)C=C(/C)C(=O)NC1=C[C@@](O)(C=CC=CC=CC(=O)NC2C(=O)CCC2=O)[C@@H]2OC2C1=O,88
BRD-K83322645,L-693403,C(N1CCC2(CCc3ccccc23)CC1)c1ccccc1,33
BRD-A92826379,lupanine,O=C1CCCC2C3CC(CN12)[C@@H]1CCCCN1C3,34
BRD-K53318339,vinpocetine,CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c([C@H]23)n1c1ccccc41,51
BRD-K72029282,probucol,CC(C)(Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C)Sc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C,71
BRD-K31928526,barasertib,CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(O)(O)=O,68
BRD-K07881437,danusertib,CO[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(cc3)N3CCN(C)CC3)c2C1)c1ccccc1,67
BRD-K36740062,GSK-1070916,CCn1cc(c(n1)-c1ccc(NC(=O)N(C)C)cc1)-c1ccnc2[nH]c(cc12)-c1cccc(CN(C)C)c1,71
BRD-K53665955,MK-5108,OC(=O)[C@@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](CC1)Oc1cccc(Cl)c1F,60
BRD-K72703948,ZM-447439,COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1,55
BRD-K90239174,AMG-487,CCOc1ccc(cc1)-n1c(nc2ncccc2c1=O)[C@@H](C)N(Cc1cccnc1)C(=O)Cc1ccc(OC(F)(F)F)cc1,78
BRD-A04352665,maraviroc,CC(C)c1nnc(C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1,66
BRD-K14175878,MK-0812,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](C1)(C(C)C)C(=O)N1CCc2ncc(cc2C1)C(F)(F)F,74
BRD-K82850175,navarixin,CC[C@@H](Nc1c(Nc2cccc(C(=O)N(C)C)c2O)c(=O)c1=O)c1ccc(C)o1,57
BRD-K33240821,plerixafor,C(N1CCCNCCNCCCNCC1)c1ccc(CN2CCCNCCNCCCNCC2)cc1,46
BRD-A44863528,proglumide,CCCN(CCC)C(=O)C(CCC(O)=O)NC(=O)c1ccccc1,39
BRD-K58486055,reparixin,CC(C)Cc1ccc(cc1)[C@@H](C)C(=O)NS(C)(=O)=O,41
BRD-K87510569,RS-504393,Cc1oc(nc1CCN1CCC2(CC1)OC(=O)Nc1ccc(C)cc21)-c1ccccc1,51
BRD-K61323504,SB-225002,Oc1cc(ccc1NC(=O)Nc1ccccc1Br)[N+]([O-])=O,40
BRD-K35629949,SR-27897,OC(=O)Cn1c(cc2ccccc12)C(=O)Nc1nc(cs1)-c1ccccc1Cl,48
BRD-K84748119,vicriviroc,COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F,74
BRD-K07220430,cinnarizine,C(/C=C/c1ccccc1)N2CCN(CC2)C(c3ccccc3)c4ccccc4,45
BRD-K19462402,buflomedil,COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1,35
BRD-A43331270,niguldipine,CCCN1C(C)=C(C(c2cccc(c2)[N+]([O-])=O)C(C(=O)ON2CCC(CC2)(c2ccccc2)c2ccccc2)=C1C)C(=O)OC,86
BRD-K81458380,CX-4945,OC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc21,43
BRD-A20348246,chlormezanone,CN1C(c2ccc(Cl)cc2)S(=O)(=O)CCC1=O,33
BRD-K50422030,clomethiazole,Cc1ncsc1CCCl,12
BRD-A54880345,etomidate,CCOC(=O)c1cncn1C(C)c1ccccc1,27
BRD-K42417338,butorphanol-(+)-tartrate,Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]4(CCCC[C@@]34O)c2c1,50
BRD-K61250553,loperamide,CN(C)C(=O)C(CCN1CCC(O)(CC1)c1ccc(Cl)cc1)(c1ccccc1)c1ccccc1,58
BRD-K66404838,nalbuphine,O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC1CCC1)c45,64
BRD-K51033547,tramadol,COc1cccc(c1)[C@]1(O)CCCC[C@H]1CN(C)C,36
BRD-A92630576,trimebutine,CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(N(C)C)c1ccccc1,47
BRD-K52818472,ivacaftor,CC(C)(C)c1cc(c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O)C(C)(C)C,54
BRD-K57222227,indometacin,COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)O)c2c1,46
BRD-A72066420,mifobate,COP(=O)(OC)OC(c1ccc(Cl)cc1)P(=O)(OC)OC,38
BRD-K71879491,tretinoin,CC(/C=C/C1=C(C)CCCC1(C)C)=CC=CC(C)=CC(O)=O,42
BRD-A93255169,thalidomide,O=C1N(C2CCC(=O)NC2=O)C(=O)c2ccccc12,35
BRD-K02314383,epitiostanol,C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H]5S[C@@H]5C[C@]34C)[C@@H]1CC[C@@H]2O,72
BRD-K92467929,oxandrolone,C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)OC[C@]4(C)[C@H]3CC[C@]12C,63
BRD-K89657519,testosterone-enanthate,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,69
BRD-A48720949,testosterone-propionate,CCC(=O)O[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C,52
BRD-A82522119,tibolone,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@H](CC[C@@]3(O)C#C)C12,65
BRD-K73838513,cinacalcet,C[C@@H](NCCCc1cccc(c1)C(F)(F)F)c1cccc2ccccc12,45
BRD-K37714784,ABT-724,C(N1CCN(CC1)c1ccccn1)c1nc2ccccc2[nH]1,37
BRD-A80151636,bromocriptine,CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]2CCCN2C1=O)C(C)C,98
BRD-K86882815,cabergoline,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(CC=C)C1,73
BRD-K43887077,dopamine,NCCc1ccc(O)c(O)c1,17
BRD-A50684349,fenoldopam,Oc1ccc(cc1)C1CNCCc2c(Cl)c(O)c(O)cc12,36
BRD-K91336023,mesulergine,CN(C)S(=O)(=O)N[C@H]1C[C@H]2[C@@H](Cc3cn(C)c4cccc2c34)N(C)C1,60
BRD-A72309220,metergoline,CN1CC(CNC(=O)OCc2ccccc2)C[C@@H]2C1Cc1cn(C)c3cccc2c13,52
BRD-K47936004,piribedil,C(N1CCN(CC1)c1ncccn1)c1ccc2OCOc2c1,34
BRD-A60070924,alpha-estradiol,CC12CCC3C(CCc4cc(O)ccc34)C1CCC2O,32
BRD-K95309561,dienestrol,CC=C(c1ccc(O)cc1)C(c1ccc(O)cc1)=CC,34
BRD-K54847683,equol,Oc1ccc(cc1)[C@H]1COc2cc(O)ccc2C1,32
BRD-K80608265,erteberel,Oc1ccc(cc1)[C@@H]1Oc2ccc(O)cc2[C@@H]2CCC[C@H]12,47
BRD-K18910433,estradiol,C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O,54
BRD-A91452556,estradiol-cypionate,C[C@]12CCC3C(CCc4cc(O)ccc34)C1CC[C@@H]2OC(=O)CCC1CCCC1,54
BRD-K17016787,estriol,C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1C[C@@H](O)[C@@H]2O,62
BRD-A37959677,estrone,C[C@]12CCC3C(CCc4cc(O)ccc34)C1CCC2=O,36
BRD-K35189033,levonorgestrel,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,65
BRD-A14798026,mestranol,COc1ccc2C3CC[C@@]4(C)C(CC[C@@]4(O)C#C)C3CCc2c1,46
BRD-K28936863,ketotifen,CN1CCC(CC1)=C1c2ccsc2C(=O)Cc2ccccc12,36
BRD-K06854232,AM-580,CC1(C)CCC(C)(C)c2cc(ccc12)C(=O)Nc1ccc(cc1)C(O)=O,48
BRD-K92441787,bexarotene,Cc1cc2c(cc1C(=C)c1ccc(cc1)C(O)=O)C(C)(C)CCC2(C)C,48
BRD-K25737009,CD-1530,OC(=O)c1ccc(cc1)c2ccc3cc(c(O)cc3c2)C4(CC5CC6CC(C5)C4)C6,55
BRD-K83794243,palovarotene,CC1(C)CCC(C)(C)c2cc(C=Cc3ccc(cc3)C(O)=O)c(Cn3cccn3)cc12,55
BRD-K36627727,tamibarotene,CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(cc3)C(O)=O)ccc12,48
BRD-K76841105,tazarotene,CCOC(=O)c1ccc(nc1)C#Cc1ccc2SCCC(C)(C)c2c1,41
BRD-K49685476,TTNPB,CC(=C/c1ccc(cc1)C(O)=O)c1ccc2c(c1)C(C)(C)CCC2(C)C,49
BRD-A15435692,BMY-14802,OC(CCCN1CCN(CC1)c1ncc(F)cn1)c1ccc(F)cc1,39
BRD-K43797669,genistein,Oc1ccc(cc1)-c1coc2cc(O)cc(O)c2c1=O,34
BRD-K02123250,JNJ-38877605,Cn1cc(cn1)-c1ccc2nnc(n2n1)C(F)(F)c1ccc2ncccc2c1,47
BRD-K02965346,SU-11274,CN(c1cccc(Cl)c1)S(=O)(=O)c1ccc2NC(=O)C(=C/c3[nH]c(C)c(C(=O)N4CCN(C)CC4)c3C)c2c1,79
BRD-K33379087,tivantinib,O=C1NC(=O)[C@H]([C@@H]1c1c[nH]c2ccccc12)c1cn2CCCc3cccc1c23,58
BRD-A81866333,CGS-21680,CCNC(=O)C1OC(C(O)C1O)n2cnc3c(N)nc(NCCc4ccc(CCC(=O)O)cc4)nc23,60
BRD-A64933752,CV-1808,Nc1nc(Nc2ccccc2)nc3n(cnc13)C4OC(CO)C(O)C4O,42
BRD-A78341343,regadenoson,CNC(=O)c1cnn(c1)-c1nc(N)c2ncn([C@@H]3O[C@H](CO)C(O)C3O)c2n1,59
BRD-K62581435,3-MPPI,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c4ccccc4[nH]c3c2=O)CC1,53
BRD-K62309135,L-glutamic-acid,N[C@@H](CCC(O)=O)C(O)=O,23
BRD-K88611939,aniracetam,COc1ccc(cc1)C(=O)N1CCCC1=O,26
BRD-K65359424,eglumetad,N[C@]1(CC[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O,44
BRD-K49519144,LY-2140023,N[C@]1(CS(=O)(=O)[C@H]2[C@@H]([C@@H]12)C(O)=O)C(O)=O,52
BRD-A02508087,NMDA,CNC(CC(O)=O)C(O)=O,18
BRD-A59709458,PHCCC,ON=C1/C2CC2(Oc2ccccc12)C(=O)Nc1ccccc1,37
BRD-K44827188,vismodegib,Clc1cc(ccc1C(=O)Nc1ccc(Cl)c(c1)-c1ccccn1)S(C)(=O)=O,51
BRD-K84698278,agomelatine,COc1ccc2cccc(CCNC(C)=O)c2c1,27
BRD-K97530723,melatonin,COc1ccc2[nH]cc(CCNC(C)=O)c2c1,29
BRD-K07857022,alvimopan,C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(O)=O)CC[C@@]1(C)c1cccc(O)c1,63
BRD-K84810405,almorexant,CNC(=O)[C@H](N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc1ccc(cc1)C(F)(F)F)c1ccccc1,69
BRD-K94293891,suvorexant,C[C@@H]1CCN(CCN1C(=O)c1cc(C)ccc1-n1nccn1)c1nc2cc(Cl)ccc2o1,58
BRD-K67789209,adatanserin,O=C(NCCN1CCN(CC1)c1ncccn1)C12CC3CC(CC(C3)C1)C2,46
BRD-K70358946,aripiprazole,Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl,47
BRD-K93461745,buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1,44
BRD-A12896037,cisapride,COC1CN(CCCOc2ccc(F)cc2)CCC1NC(=O)c1cc(Cl)c(N)cc1OC,50
BRD-K42348709,cyclobenzaprine,CN(C)CCC=C1c2ccccc2C=Cc2ccccc12,31
BRD-K55013654,lorcaserin,C[C@H]1CNCCc2ccc(Cl)cc12,24
BRD-K75699339,rizatriptan,CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12,33
BRD-K50938287,sumatriptan,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1,37
BRD-K53963539,vortioxetine,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1,31
BRD-A07780951,orciprenaline,CC(C)NCC(O)c1cc(O)cc(O)c1,25
BRD-A75726477,clenbuterol,CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1,33
BRD-K98530306,clonidine,Clc1cccc(Cl)c1N=C1NCCN1,23
BRD-A97104540,fenoterol,CC(Cc1ccc(O)cc1)NCC(O)c1cc(O)cc(O)c1,36
BRD-K54006094,formoterol,COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1,49
BRD-K56800335,guanaben-acetate,NC(=N)NN=C/c1c(Cl)cccc1Cl,25
BRD-K48578705,methyldopa,C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O,31
BRD-A79981887,midodrine,COc1ccc(OC)c(c1)C(O)CNC(=O)CN,29
BRD-K73381542,phenylephrine,CNC[C@H](O)c1cccc(O)c1,22
BRD-A22684332,procaterol,CCC(NC(C)C)C(O)c1ccc(O)c2[nH]c(=O)ccc12,39
BRD-K01638814,rilmenidine,C1CC1C(NC1=NCCO1)C1CC1,22
BRD-A59174698,ritodrine,CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1,33
BRD-A01320529,salmeterol,OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc1ccccc1,38
BRD-K82164249,andarine,CC(=O)Nc1ccc(OC[C@](C)(O)C(=O)Nc2ccc(c(c2)C(F)(F)F)[N+]([O-])=O)cc1,67
BRD-K38868394,MK-0773,CN1[C@@H]2CC[C@H]3[C@@H]4CC[C@H](C(=O)NCc5nc6cccnc6[nH]5)[C@@]4(C)CC[C@@H]3[C@@]2(C)C=C(F)C1=O,94
BRD-K44067360,flufenamic-acid,OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F,33
BRD-A51078674,diclofensine,COc1ccc2C(CN(C)Cc2c1)c1ccc(Cl)c(Cl)c1,37
BRD-K53508936,CTS-1027,ONC(=O)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1,50
BRD-K47029922,tranylcypromine,N[C@@H]1C[C@H]1c1ccccc1,23
BRD-K45924332,amrinone,Nc1cc(c[nH]c1=O)-c1ccncc1,25
BRD-K62200014,anagrelide,Clc1ccc2N=C3NC(=O)CN3Cc2c1Cl,28
BRD-K93208532,apremilast,CCOc1cc(ccc1OC)[C@@H](CS(C)(=O)=O)N1C(=O)c2cccc(NC(C)=O)c2C1=O,62
BRD-K33852358,arofylline,CCCn1c(=O)n(-c2ccc(Cl)cc2)c2[nH]cnc2c1=O,40
BRD-K65781196,avanafil,COc1ccc(CNc2nc(ncc2C(=O)NCc2ncccn2)N2CCC[C@H]2CO)cc1Cl,54
BRD-K02404261,caffeine,Cn1cnc2n(C)c(=O)n(C)c(=O)c12,28
BRD-K38473998,cilomilast,COc1ccc(cc1OC1CCCC1)C1(CCC(CC1)C(O)=O)C#N,41
BRD-K28578425,cilostamide,CN(C1CCCCC1)C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1,42
BRD-K67017579,cilostazol,O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1,38
BRD-K86301799,dipyridamole,OCCN(CCO)c1nc(N2CCCCC2)c2nc(nc(N3CCCCC3)c2n1)N(CCO)CCO,54
BRD-K35007173,enprofylline,CCCn1c2nc[nH]c2c(=O)[nH]c1=O,28
BRD-K64755930,etazolate,CCOC(=O)c1cnc2n(CC)ncc2c1NN=C(C)C,33
BRD-K74195153,irsogladine,Nc1nc(N)nc(n1)-c1cc(Cl)ccc1Cl,29
BRD-K67080878,milrinone,Cc1[nH]c(=O)c(cc1-c1ccncc1)C#N,30
BRD-K82967685,mirodenafil,CCCOc1ccc(cc1-c1nc2c(CCC)cn(CC)c2c(=O)[nH]1)S(=O)(=O)N1CCN(CCO)CC1,66
BRD-K20745393,olprinone,Cc1[nH]c(=O)c(cc1-c1ccc2nccn2c1)C#N,35
BRD-K15567136,papaverine,COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC,37
BRD-K57569181,pentoxifylline,CC(=O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O,35
BRD-K31519811,PF-02545920,Cn1cc(c(n1)-c1ccc(OCc2ccc3ccccc3n2)cc1)-c1ccncc1,48
BRD-K47642186,piclamilast,COc1ccc(cc1OC1CCCC1)C(=O)Nc1c(Cl)cncc1Cl,40
BRD-K59273480,propentofylline,CCCn1cnc2n(C)c(=O)n(CCCCC(C)=O)c(=O)c12,39
BRD-A07207424,Ro-20-1724,CCCCOc1cc(CC2CNC(=O)N2)ccc1OC,29
BRD-K03194791,roflumilast,FC(F)Oc1ccc(cc1OCC1CC1)C(=O)Nc1c(Cl)cncc1Cl,43
BRD-A34255068,rolipram,COc1ccc(cc1OC1CCCC1)C1CNC(=O)C1,31
BRD-A62071884,siguazodan,CNC(NC#N)=N/c1ccc(cc1)C1=NNC(=O)CC1C,36
BRD-K79759585,sildenafil,CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(C)CC1,60
BRD-K63516691,T-0156,COC(=O)c1c(-c2cc(OC)c(OC)c(OC)c2)c2ccnc(OCc3ncccn3)c2c(=O)n1Cc1ccnc(C)c1,72
BRD-K93645900,tadalafil,CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c2ccc3OCOc3c2)C1=O,60
BRD-K13926615,vardenafil,CCCc1nc(C)c2n1nc([nH]c2=O)-c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC)CC1,61
BRD-K12932420,YM-976,CCc1ccc2c(nc(=O)n(CC)c2n1)-c1cccc(Cl)c1,39
BRD-K37561857,zardaverine,COc1cc(ccc1OC(F)F)-c1ccc(=O)[nH]n1,34
BRD-A45153512,bimatoprost,CCNC(=O)CCCC=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1C=CC(O)CCc1ccccc1,65
BRD-K28912512,nicotinamide,NC(=O)c1cccnc1,14
BRD-K09132007,D-4476,NC(=O)c1ccc(cc1)-c1nc(c([nH]1)-c1ccccn1)-c1ccc2OCCOc2c1,55
BRD-K96862998,pirfenidone,Cc1ccc(=O)n(c1)-c1ccccc1,24
BRD-K37720887,SB-525334,Cc1cccc(n1)-c1[nH]c(nc1-c1ccc2nccnc2c1)C(C)(C)C,47
BRD-A29485665,bicalutamide,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(c1)C(F)(F)F,57
BRD-K56851771,enzalutamide,CNC(=O)c1ccc(cc1F)N1C(=S)N(C(=O)C1(C)C)c1ccc(C#N)c(c1)C(F)(F)F,62
BRD-K28307902,flutamide,CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+]([O-])=O,43
BRD-A66116161,AM-1241,CN1CCCCC1Cn1cc(C(=O)c2cc(ccc2I)[N+]([O-])=O)c2ccccc12,53
BRD-K42352790,anandamide,CCCCCC=C/CC=C/CC=C/CC=C/CCCC(=O)NCCO,36
BRD-K10705233,GW-405833,COc1ccc2n(C(=O)c3cccc(Cl)c3Cl)c(C)c(CCN3CCOCC3)c2c1,51
BRD-K17796732,JWH-015,CCCn1c(C)c(C(=O)c2cccc3ccccc23)c4ccccc14,40
BRD-K62289640,lylamine,CC(C)c1ccc2c(CC[C@H]3[C@](C)(CN)CCC[C@]23C)c1,45
BRD-K68095457,palmitoylethanolamide,CCCCCCCCCCCCCCCC(=O)NCCO,24
BRD-K75037734,carbachol,C[N+](C)(C)CCOC(N)=O,20
BRD-K95260951,asenapine,CN1C[C@H]2[C@H](C1)c1cc(Cl)ccc1Oc1ccccc21,41
BRD-K57764956,cariprazine,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2cccc(Cl)c2Cl)CC1,55
BRD-K37289225,clozapine,CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2ccccc12,37
BRD-K97158071,droperidol,Fc1ccc(cc1)C(=O)CCCN1CCC(=CC1)n1c2ccccc2[nH]c1=O,48
BRD-K55127134,fluphenazine,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1,46
BRD-K77947974,fluspirilene,Fc1ccc(cc1)C(CCCN1CCC2(CC1)N(CNC2=O)c1ccccc1)c1ccc(F)cc1,56
BRD-K67783091,haloperidol,OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c1ccc(Cl)cc1,44
BRD-K96740444,itopride,COc1ccc(cc1OC)C(=O)NCc1ccc(OCCN(C)C)cc1,39
BRD-K51671335,levosulpiride,CCN1CCC[C@H]1CNC(=O)c1cc(ccc1OC)S(N)(=O)=O,42
BRD-K51143828,lurasidone,O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(CC1)c1nsc2ccccc12,84
BRD-K92984783,melperone,CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1,30
BRD-K75641298,metoclopramide,CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,32
BRD-A65280694,molindone,CCc1c(C)[nH]c2CCC(CN3CCOCC3)C(=O)c12,36
BRD-M80207679,nemonapride,CNc1cc(OC)c(cc1Cl)C(=O)N[C@@H]1CCN(Cc2ccccc2)[C@@H]1C.CNc1cc(OC)c(cc1Cl)C(=O)N[C@H]1CCN(Cc2ccccc2)[C@H]1C,105
BRD-K01292756,pimozide,Fc1ccc(cc1)C(CCCN1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc(F)cc1,56
BRD-K19352500,prochlorperazine,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc23)CC1,38
BRD-K68867920,quetiapine,OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2ccccc12,38
BRD-K53857191,risperidone,Cc1nc2CCCCn2c(=O)c1CCN1CCC(CC1)c1noc2cc(F)ccc12,47
BRD-K69116396,sertindole,Fc1ccc(cc1)-n1cc(C2CCN(CCN3CCNC3=O)CC2)c2cc(Cl)ccc12,52
BRD-A84481105,thioridazine,CSc1ccc2Sc3ccccc3N(CCC3CCCCN3C)c2c1,35
BRD-K97309399,thiothixene,CN(C)S(=O)(=O)c1ccc2Sc3ccccc3C(=C/CCN3CCN(C)CC3)c2c1,52
BRD-K57432881,tiapride,CCN(CC)CCNC(=O)c1cc(ccc1OC)S(C)(=O)=O,37
BRD-K89732114,trifluoperazine,CN1CCN(CCCN2c3ccccc3Sc3ccc(cc23)C(F)(F)F)CC1,44
BRD-K63675182,triflupromazine,CN(C)CCCN1c2ccccc2Sc2ccc(cc12)C(F)(F)F,38
BRD-K04218075,clomifene,CCN(CC)CCOc1ccc(cc1)/C(=C(/Cl)c2ccccc2)/c3ccccc3,48
BRD-K29950728,clomifene,CCN(CC)CCOc1ccc(cc1)C(=C(/Cl)c1ccccc1)c1ccccc1,46
BRD-A92537424,danazol,C[C@]12CCC3C(CCC4=Cc5oncc5C[C@]34C)C1CC[C@@]2(O)C#C,51
BRD-A03249105,fulvestrant,C[C@]12CC[C@H]3C([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc1cc(O)ccc31,87
BRD-A90490067,fulvestrant,CC12CCC3C(C2CCC1O)C(CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc4cc(O)ccc34,66
BRD-K63828191,raloxifene,Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1,54
BRD-K93754473,tamoxifen,CCC(c1ccccc1)=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1,44
BRD-K67174588,toremifene,CN(C)CCOc1ccc(cc1)C(=C(/CCCl)c1ccccc1)c1ccccc1,46
BRD-K79501723,cyclizine,CN1CCN(CC1)C(c1ccccc1)c1ccccc1,30
BRD-K77771411,moxonidine,COc1nc(C)nc(Cl)c1NC1=NCCN1,26
BRD-K52080565,nandrolone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O,60
BRD-K38436528,imipramine,CN(C)CCCN1c2ccccc2CCc2ccccc12,29
BRD-K02867583,minaprine,Cc1cc(nnc1NCCN1CCOCC1)-c1ccccc1,31
BRD-K70778732,trazodone,Clc1cccc(c1)N1CCN(CCCn2nc3ccccn3c2=O)CC1,40
BRD-K58010567,vilazodone,NC(=O)c1cc2cc(ccc2o1)N1CCN(CCCCc2c[nH]c3ccc(cc23)C#N)CC1,56
BRD-K79877282,PF-543,Cc1cc(CS(=O)(=O)c2ccccc2)cc(OCc2ccc(CN3CCC[C@@H]3CO)cc2)c1,58
BRD-A38350138,ketoconazole,CC(=O)N1CCN(CC1)c1ccc(OCC2CO[C@@](Cn3ccnc3)(O2)c2ccc(Cl)cc2Cl)cc1,65
BRD-A49399758,desmopressin-acetate,NC(=O)CCC1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccc(O)cc2)NC(=O)CCSSCC(NC(=O)C(CC(N)=O)NC1=O)C(=O)N1CCCC1C(=O)NC(CCCNC(N)=N)C(=O)NCC(N)=O,128
BRD-K97799481,theophylline,Cn1c2nc[nH]c2c(=O)n(C)c1=O,26
BRD-K49049886,CGS-15943,Nc1nc2ccc(Cl)cc2c2nc(nn12)-c1ccco1,34
BRD-K70507123,doxofylline,Cn1c2ncn(CC3OCCO3)c2c(=O)n(C)c1=O,33
BRD-K83064458,etofylline,Cn1c2ncn(CCO)c2c(=O)n(C)c1=O,28
BRD-K87774949,istradefylline,CCn1c2nc(C=Cc3ccc(OC)c(OC)c3)n(C)c2c(=O)n(CC)c1=O,49
BRD-K37618799,MRS-1220,Clc1ccc2nc(NC(=O)Cc3ccccc3)n3nc(nc3c2c1)-c1ccco1,48
BRD-K46290096,preladenant,COCCOc1ccc(cc1)N1CCN(CCn2ncc3c2nc(N)n2nc(nc32)-c2ccco2)CC1,58
BRD-K10177585,PSB-11,CC[C@@H]1CN2C(=N1)c1[nH]c(nc1N(C)C2=O)-c1ccccc1,47
BRD-K49027941,PSB-1115,CCCn1c(=O)[nH]c2nc([nH]c2c1=O)-c1ccc(cc1)S(O)(=O)=O,51
BRD-A70407468,PSB-36,CCCCn1c(=O)n(CCCO)c2nc([nH]c2c1=O)C12CC3CC1CC(C2)C3,51
BRD-K81225797,SCH-58261,Nc1nc2n(CCc3ccccc3)ncc2c2nc(nn12)-c1ccco1,41
BRD-K34445261,SLV-320,O[C@H]1CC[C@@H](CC1)Nc1nc(nc2[nH]ccc12)-c1ccccc1,48
BRD-K93045741,tozadenant,COc1ccc(N2CCOCC2)c2sc(NC(=O)N3CCC(C)(O)CC3)nc12,47
BRD-K19605405,ZM-241385,Nc1nc(NCCc2ccc(O)cc2)nc2nc(nn12)-c1ccco1,40
BRD-K62734952,arglabin,CC1=CC[C@]23O[C@@]2(C)CC[C@@H]2[C@H](OC(=O)C2=C)[C@@H]13,56
BRD-K41599323,lonafarnib,NC(=O)N1CCC(CC(=O)N2CCC(CC2)[C@H]2c3ncc(Br)cc3CCc3cc(Cl)cc(Br)c23)CC1,69
BRD-K52075040,cerulenin,CC=CCC=CCCC(=O)[C@H]1O[C@H]1C(N)=O,34
BRD-K28667793,pyrazinamide,NC(=O)c1cnccn1,14
BRD-K23163214,dizocilpine,C[C@@]12N[C@@H](Cc3ccccc13)c1ccccc21,36
BRD-K63919159,aptiganel,CCc1cccc(c1)N(C)C(=N)Nc1cccc2ccccc12,36
BRD-K62387885,basimglurant,Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(F)cc1,40
BRD-K18324993,budipine,CC(C)(C)N1CCC(CC1)(c1ccccc1)c1ccccc1,36
BRD-K99107520,felbamate,NC(=O)OCC(COC(N)=O)c1ccccc1,27
BRD-K41160163,fenobam,CN1CC(=O)N=C1NC(=O)Nc1cccc(Cl)c1,32
BRD-K10176267,L-701252,Oc1c(C(=O)C2CC2)c(=O)[nH]c2cc(Cl)ccc12,38
BRD-K08109516,L-701324,Oc1c(-c2cccc(Oc3ccccc3)c2)c(=O)[nH]c2cc(Cl)ccc12,48
BRD-K55703048,latrepirdine,CN1CCc2c(C1)c1cc(C)ccc1n2CCc1ccc(C)nc1,38
BRD-K87696786,LY-456236,COc1ccc(Nc2ncnc3ccc(OC)cc23)cc1,31
BRD-A23970436,thiamylal,CCCC(C)C1(CC=C)C(=O)NC(S)=NC1=O,31
BRD-K38158531,traxoprodil,C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(CC1)c1ccccc1,50
BRD-K48059230,YM-298198,Cc1c(sc2nc3ccc(N)cc3n12)C(=O)NC1CCCCC1,38
BRD-K50163129,acrivastine,Cc1ccc(cc1)C(=C/CN1CCCC1)c1cccc(C=CC(O)=O)n1,44
BRD-A68888262,azelastine,CN1CCCC(CC1)n1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O,43
BRD-K79595931,bavisant,O=C(N1CCN(CC1)C1CC1)c1ccc(CN2CCOCC2)cc1,39
BRD-K98624455,bepotastine,OC(=O)CCCN1CCC(CC1)O[C@@H](c1ccc(Cl)cc1)c1ccccn1,48
BRD-K34157611,cimetidine,CNC(NCCSCc1nc[nH]c1C)=N/C#N,27
BRD-K37694030,doxepin,CN(C)CCC=C1c2ccccc2COc2ccccc12,30
BRD-K15010214,emedastine,CCOCCn1c(nc2ccccc12)N1CCCN(C)CC1,32
BRD-A73368467,fexofenadine,CC(C)(C(O)=O)c1ccc(cc1)C(O)CCCN1CCC(CC1)C(O)(c1ccccc1)c1ccccc1,62
BRD-A67616246,levomequitazine,C(C1CN2CCC1CC2)N1c2ccccc2Sc2ccccc12,35
BRD-K82795137,loratadine,CCOC(=O)N1CCC(CC1)=C1c2ccc(Cl)cc2CCc2cccnc12,44
BRD-K97564742,mepyramine,COc1ccc(cc1)CN(CCN(C)C)c1ccccn1,31
BRD-K70505054,ranitidine,CNC(NCCSCc1ccc(CN(C)C)o1)=C/[N+]([O-])=O,40
BRD-K98004573,rupatadine,Cc1cncc(CN2CCC(CC2)=C2c3ccc(Cl)cc3CCc3cccnc23)c1,48
BRD-K34415467,trimethobenzamide,COc1cc(cc(OC)c1OC)C(=O)NCc1ccc(OCCN(C)C)cc1,43
BRD-K64504314,dienogest,C[C@@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)CC#N,56
BRD-A61221616,medroxyprogesterone-acetate,C[C@H]1CC2C3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CCC2[C@@]2(C)CCC(=O)C=C12,69
BRD-K99604664,tanaproget,Cn1c(ccc1-c1ccc2NC(=S)OC(C)(C)c2c1)C#N,38
BRD-K49671696,ketanserin,Fc1ccc(cc1)C(=O)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1,51
BRD-A50764878,MDL-73005EF,O=C1CC2(CCCC2)CC(=O)N1CCNCC1COc2ccccc2O1,40
BRD-A64977602,mirtazapine,CN1CCN2C(C1)c1ccccc1Cc1cccnc21,30
BRD-K90825648,RS-127445,CC(C)c1cc(nc(N)n1)-c1ccc(F)c2ccccc12,36
BRD-K82467063,SB-271046,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1,48
BRD-K59715032,pasireotide,NCCCC[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(OCc3ccccc3)cc2)NC1=O)OC(=O)NCCN)c1ccccc1,159
BRD-K85090592,pilocarpine,CC[C@H]1[C@@H](Cc2cncn2C)COC1=O,31
BRD-A89175223,bisoprolol,CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1,33
BRD-A10977446,carvedilol,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,43
BRD-A13188892,doxazosin,COc1cc2nc(nc(N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2ccccc2O1,52
BRD-K76953762,indoramin,O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1,42
BRD-K76810206,nicergoline,CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13,66
BRD-K90333595,phentolamine,Cc1ccc(cc1)N(CC1=NCCN1)c1cccc(O)c1,34
BRD-A97701745,pindolol,CC(C)NCC(O)COc1cccc2[nH]ccc12,29
BRD-K49111258,prazosin,COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4ccco4,45
BRD-K74339692,tamsulosin,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(c1)S(N)(=O)=O,48
BRD-K73196317,urapidil,COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1,44
BRD-K41185545,ambrisentan,COC([C@H](Oc1nc(C)cc(C)n1)C(O)=O)(c1ccccc1)c1ccccc1,51
BRD-K16295392,atrasentan,CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1c1ccc(OC)cc1)C(O)=O)c1ccc2OCOc2c1,73
BRD-K56509348,BMS-182874,CN(C)c1cccc2c(cccc12)S(=O)(=O)Nc1onc(C)c1C,42
BRD-K74763371,bosentan,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(cc2)C(C)(C)C)nc(nc1OCCO)-c1ncccn1,64
BRD-K48812570,macitentan,CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1,53
BRD-K63806092,sitaxentan,Cc1noc(NS(=O)(=O)c2ccsc2C(=O)Cc2cc3OCOc3cc2C)c1Cl,49
BRD-K31553034,zibotentan,COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(cc1)-c1nnco1,50
BRD-K37764012,PF-03758309,CN(C)C[C@@H](NC(=O)N1Cc2c(Nc3nc(C)nc4ccsc34)n[nH]c2C1(C)C)c1ccccc1,66
BRD-A90547603,eptifibatide,NC(=N)NCCCCC1NC(=O)CCSSCC(NC(=O)C2CCCN2C(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CC(O)=O)NC(=O)CNC1=O)C(N)=O,99
BRD-K37872686,tirofiban,CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(O)=O,52
BRD-K48894757,laropiprant,CS(=O)(=O)c1cc(F)cc2c3CC[C@H](CC(O)=O)c3n(Cc3ccc(Cl)cc3)c12,59
BRD-K08586861,ramatroban,OC(=O)CCn1c2CC[C@H](Cc2c2ccccc12)NS(=O)(=O)c1ccc(F)cc1,54
BRD-K52512893,SC-19220,CC(=O)NNC(=O)N1Cc2ccccc2Oc2ccc(Cl)cc12,38
BRD-K44974079,ticagrelor,CCCSc1nc(N[C@@H]2C[C@@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@H](O)[C@H]3O)c2n1,85
BRD-K00603606,ticlopidine,Clc1ccccc1CN1CCc2sccc2C1,24
BRD-K50498985,taladegib,CN(C1CCN(CC1)c1nnc(-c2ccnn2C)c2ccccc12)C(=O)c1ccc(F)cc1C(F)(F)F,63
BRD-K67277431,picotamide,COc1ccc(cc1C(=O)NCc1cccnc1)C(=O)NCc1cccnc1,42
BRD-K84091759,candesartan,CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1,55
BRD-K60038276,irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1,55
BRD-K76205745,losartan,CCCCc1nc(Cl)c(CO)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1,50
BRD-K78485176,olmesartan-medoxomil,CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1,72
BRD-K73999723,telmisartan,CCCc1nc2c(C)cc(cc2n1Cc1ccc(cc1)-c1ccccc1C(O)=O)-c1nc2ccccc2n1C,62
BRD-K45158365,valsartan,CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[nH]n1)[C@@H](C(C)C)C(O)=O,62
BRD-K68103045,CGS-20625,COc1ccc(cc1)-n1nc2c3CCCCCc3[nH]cc2c1=O,38
BRD-K16508793,diazepam,CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccccc1,33
BRD-K68232413,etizolam,CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl,38
BRD-A11990600,lorazepam,OC1N=C(c2ccccc2Cl)c2cc(Cl)ccc2NC1=O,35
BRD-K92657060,zaleplon,CCN(C(C)=O)c1cccc(c1)-c1ccnc2c(cnn12)C#N,40
BRD-K33882852,ZK-93423,CCOC(=O)c1ncc2[nH]c3ccc(OCc4ccccc4)cc3c2c1COC,45
BRD-K44876623,zolpidem,CN(C)C(=O)Cc1c(nc2ccc(C)cn12)-c1ccc(C)cc1,41
BRD-K92000912,AM-251,Cc1c(nn(c1-c1ccc(I)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1,53
BRD-K59419204,AM-281,Cc1c(nn(c1-c1ccc(I)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCOCC1,53
BRD-K63533170,AM-630,COc1ccc(cc1)C(=O)c1c(C)n(CCN2CCOCC2)c2cc(I)ccc12,48
BRD-K78637815,LY-320135,COc1ccc(cc1)-c1oc2cc(OC)ccc2c1C(=O)c1ccc(cc1)C#N,48
BRD-K13296708,rimonabant,Cc1c(nn(c1-c1ccc(Cl)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1,54
BRD-K43578482,defactinib,CNC(=O)c1ccc(Nc2ncc(c(NCc3nccnc3N(C)S(C)(=O)=O)n2)C(F)(F)F)cc1,62
BRD-K99545815,PF-562271,CN(c1ncccc1CNc1nc(Nc2ccc3NC(=O)Cc3c2)ncc1C(F)(F)F)S(C)(=O)=O,60
BRD-A36010170,amcinonide,CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1CC1C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C,91
BRD-A69951442,dexamethasone,C[C@@H]1CC2C3CCC4=CC(=O)C=CC4(C)[C@]3(F)[C@@H](O)CC2(C)[C@]1(O)C(=O)CO,70
BRD-K62310379,fluticasone-propionate,CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF,101
BRD-A75172220,hydrocortisone,C[C@]12C[C@H](O)C3C(CCC4=CC(=O)CC[C@]34C)C1CC[C@]2(O)C(=O)CO,60
BRD-A53176877,methylprednisolone,C[C@H]1CC2C3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)C2[C@@]2(C)C=CC(=O)C=C12,72
BRD-A62525898,prednisone,C[C@]12CC(=O)C3C(CCC4=CC(=O)C=C[C@]34C)C1CC[C@]2(O)C(=O)CO,58
BRD-A37780065,triamcinolone,C[C@]12C[C@H](O)[C@@]3(F)C(CCC4=CC(=O)C=C[C@]34C)C1C[C@@H](O)[C@]2(O)C(=O)CO,76
BRD-K97045029,pranlukast,O=C(Nc1cccc2c1oc(cc2=O)-c1nnn[nH]1)c1ccc(OCCCCc2ccccc2)cc1,58
BRD-K74765201,tomelukast,CCCc1c(OCCCCc2nnn[nH]2)ccc(C(C)=O)c1O,37
BRD-K71289571,zafirlukast,COc1cc(ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12)C(=O)NS(=O)(=O)c1ccccc1C,69
BRD-A51831848,enflurane,FC(F)OC(F)(F)C(F)Cl,19
BRD-K06152156,methoxyflurane,COC(F)(F)C(Cl)Cl,16
BRD-K64931368,aminocaproic-acid,NCCCCCC(O)=O,12
BRD-K97399794,quercetin,Oc1cc(O)c2c(c1)oc(-c1ccc(O)c(O)c1)c(O)c2=O,42
BRD-K76617868,fasudil,O=S(=O)(N1CCCNCC1)c1cccc2cnccc12,32
BRD-A10523515,GSK-429286A,CC1=C(C(CC(=O)N1)c1ccc(cc1)C(F)(F)F)C(=O)Nc1cc2cn[nH]c2cc1F,59
BRD-K53814070,ripasudil,C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12,40
BRD-A58280226,Y-27632,CC(N)C1CCC(CC1)C(=O)Nc2ccncc2,29
BRD-K56751279,Y-39983,C[C@@H](N)c1ccc(cc1)C(=O)Nc1ccnc2[nH]ccc12,42
BRD-K37385792,conivaptan,Cc1nc2CCN(C(=O)c3ccc(NC(=O)c4ccccc4-c4ccccc4)cc3)c3ccccc3-c2[nH]1,65
BRD-A31095847,mozavaptan,CN(C)C1CCCN(C(=O)c2ccc(NC(=O)c3ccccc3C)cc2)c2ccccc12,52
BRD-K96720755,relcovaptan,COc1ccc(cc1OC)S(=O)(=O)N1[C@@H](C(=O)N2CCC[C@H]2C(N)=O)[C@](O)(c2cc(Cl)ccc12)c1ccccc1Cl,87
BRD-A82035391,tolvaptan,Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc23)c(C)c1,55
BRD-K21396683,marimastat,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C,57
BRD-K97472745,gestrinone,CC[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]2(O)C#C,56
BRD-K76197012,ulipristal,CN(C)c1ccc(cc1)[C@H]1C[C@@]2(C)[C@@H](CC[C@@]2(OC(C)=O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12,88
BRD-K74363950,aclidinium,OC(C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c1cccs1)c1cccs1,59
BRD-A00546892,biperiden,OC(CCN1CCCCC1)(C1CC2CC1C=C2)c1ccccc1,36
BRD-K95773607,darifenacin,NC(=O)C([C@@H]1CCN(CCc2ccc3OCCc3c2)C1)(c1ccccc1)c1ccccc1,56
BRD-A81233518,glycopyrrolate,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)c1ccccc1,43
BRD-A96060515,ipratropium,CC(C)[N+]1(C)C2CC[C@H]1C[C@H](C2)OC(=O)C(CO)c1ccccc1,52
BRD-A65013509,oxybutynin,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c1ccccc1,40
BRD-A97479839,piperidolate,CCN1CCCC(C1)OC(=O)C(c1ccccc1)c1ccccc1,37
BRD-K46692793,umeclidinium,OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2,53
BRD-K04853698,LDN-193189,C1CN(CCN1)c1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccnc2ccccc12,51
BRD-K29656036,MK-8245,OC(=O)Cn1nnc(n1)-c1cc(no1)N1CCC(CC1)Oc1cc(F)ccc1Br,50
BRD-K68392338,ZK-93426,CCOC(=O)c1ncc2[nH]c3cccc(OC(C)C)c3c2c1C,39
BRD-K45168550,SB-756050,COc1ccc(cc1OC)S(=O)(=O)N1CCCN(CC1)S(=O)(=O)c1ccc(OC)c(OC)c1,59
BRD-K83405785,pimavanserin,CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1,50
BRD-K35169477,taranabant,C[C@H](NC(=O)C(C)(C)Oc1ccc(cn1)C(F)(F)F)[C@@H](Cc1ccc(Cl)cc1)c1cccc(c1)C#N,74
BRD-K01436366,XMD-1150,COc1cc(ccc1Nc1ncc2N(C)C(=O)c3ccccc3N(C)c2n1)C(=O)N1CCC(CC1)N1CCN(C)CC1,70
BRD-K04394237,drospirenone,C[C@]12CC[C@H]3[C@@H]([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)[C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1,92
BRD-K90195324,bazedoxifene,Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12,56
BRD-K49669041,BX-912,Brc1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCc1c[nH]cn1,49
BRD-K11073688,CPI-1189,CC(=O)Nc1ccc(cc1)C(=O)NC(C)(C)C,31
BRD-K78303961,glycitein,COc1cc2c(cc1O)occ(-c1ccc(O)cc1)c2=O,35
BRD-K32405725,etomoxir,CCOC(=O)[C@@]1(CCCCCCOc2ccc(Cl)cc2)CO1,38
BRD-A19633847,perhexiline,C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1,30
BRD-K55677650,CO-101244,Cc1ccc(CC2(O)CCN(CCOc3ccc(O)cc3)CC2)cc1,39
BRD-K38183498,clonazepam,[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1,44
BRD-K97963946,EMD-1214063,CN1CCC(COc2cnc(nc2)-c2cccc(Cn3nc(ccc3=O)-c3cccc(c3)C#N)c2)CC1,61
BRD-K97233161,ABT-491,CN(C)C(=O)n1cc(C(=O)c2ccc(Cn3c(C)nc4cnccc34)c(F)c2)c2c(cccc12)C#C,65
BRD-K28115081,apafant,Cc1nnc2CN=C(c3cc(CCC(=O)N4CCOCC4)sc3-n12)c1ccccc1Cl,51
BRD-A29289453,PCA-4248,COC(=O)C1=C(C)NC(C)=C(C1C)C(=O)OCCSc1ccccc1,43
BRD-K93869735,taltirelin,CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(N)=O,68
BRD-K96936751,bretazenil,CC(C)(C)OC(=O)c1ncn-2c1[C@@H]1CCCN1C(=O)c1c(Br)cccc-21,54
BRD-A66155091,trilostane,C[C@]12CC[C@@H]3[C@@H](CC[C@@]45O[C@@H]4C(=O)C(C[C@]35C)C#N)[C@@H]1CC[C@H]2O,76
BRD-K99504665,goserelin-acetate,CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,206
